Literature DB >> 20490962

Radiation-induced cell death mechanisms.

David Eriksson1, Torgny Stigbrand.   

Abstract

The main goal when treating malignancies with radiation therapy is to deprive tumor cells of their reproductive potential. One approach to achieve this is by inducing tumor cell apoptosis. Accumulating evidences suggest that induction of apoptosis alone is insufficient to account for the therapeutic effect of radiotherapy. It has become obvious in the last few years that inhibition of the proliferative capacity of malignant cells following irradiation, especially with solid tumors, can occur via alternative cell death modalities or permanent cell cycle arrests, i.e., senescence. In this review, apoptosis and mitotic catastrophe, the two major cell deaths induced by radiation, are described and dissected in terms of activating mechanisms. Furthermore, treatment-induced senescence and its relevance for the outcome of radiotherapy of cancer will be discussed. The importance of p53 for the induction and execution of these different types of cell deaths is highlighted. The efficiency of radiotherapy and radioimmunotherapy has much to gain by understanding the cell death mechanisms that are induced in tumor cells following irradiation. Strategies to use specific inhibitors that will manipulate key molecules in these pathways in combination with radiation might potentiate therapy and enhance tumor cell kill.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20490962     DOI: 10.1007/s13277-010-0042-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  140 in total

Review 1.  Chromosome segregation and cancer: cutting through the mystery.

Authors:  P V Jallepalli; C Lengauer
Journal:  Nat Rev Cancer       Date:  2001-11       Impact factor: 60.716

Review 2.  Molecular mechanisms of caspase regulation during apoptosis.

Authors:  Stefan J Riedl; Yigong Shi
Journal:  Nat Rev Mol Cell Biol       Date:  2004-11       Impact factor: 94.444

Review 3.  Transcriptional regulation by p53: one protein, many possibilities.

Authors:  O Laptenko; C Prives
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

Review 4.  Assessing TP53 status in human tumours to evaluate clinical outcome.

Authors:  T Soussi; C Béroud
Journal:  Nat Rev Cancer       Date:  2001-12       Impact factor: 60.716

5.  Identification of a p53-dependent negative response element in the bcl-2 gene.

Authors:  T Miyashita; M Harigai; M Hanada; J C Reed
Journal:  Cancer Res       Date:  1994-06-15       Impact factor: 12.701

6.  A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents.

Authors:  B D Chang; E V Broude; M Dokmanovic; H Zhu; A Ruth; Y Xuan; E S Kandel; E Lausch; K Christov; I B Roninson
Journal:  Cancer Res       Date:  1999-08-01       Impact factor: 12.701

Review 7.  p53 induced growth arrest versus apoptosis and its modulation by survival cytokines.

Authors:  Dan A Liebermann; Barbara Hoffman; Diana Vesely
Journal:  Cell Cycle       Date:  2007-01-29       Impact factor: 4.534

8.  Constitutive p38HOG mitogen-activated protein kinase activation induces permanent cell cycle arrest and senescence.

Authors:  Rizwan Haq; James D Brenton; Mark Takahashi; Dina Finan; Ariel Finkielsztein; Sambasivarao Damaraju; Robert Rottapel; Brent Zanke
Journal:  Cancer Res       Date:  2002-09-01       Impact factor: 12.701

9.  Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction.

Authors:  Lynne W Elmore; Catherine W Rehder; Xu Di; Patricia A McChesney; Colleen K Jackson-Cook; David A Gewirtz; Shawn E Holt
Journal:  J Biol Chem       Date:  2002-07-05       Impact factor: 5.157

Review 10.  Aurora kinase inhibitors.

Authors:  J J E M Kitzen; M J A de Jonge; J Verweij
Journal:  Crit Rev Oncol Hematol       Date:  2009-04-14       Impact factor: 6.312

View more
  204 in total

1.  Gene expression profiling in MOLT-4 cells during gamma-radiation-induced apoptosis.

Authors:  Theres Lindgren; Torgny Stigbrand; Katrine Riklund; Lennart Johansson; David Eriksson
Journal:  Tumour Biol       Date:  2012-02-10

Review 2.  Clinical radioimmunotherapy--the role of radiobiology.

Authors:  Jean-Pierre Pouget; Isabelle Navarro-Teulon; Manuel Bardiès; Nicolas Chouin; Guillaume Cartron; André Pèlegrin; David Azria
Journal:  Nat Rev Clin Oncol       Date:  2011-11-08       Impact factor: 66.675

3.  Radiation-induced synthetic lethality: combination of poly(ADP-ribose) polymerase and RAD51 inhibitors to sensitize cells to proton irradiation.

Authors:  Anne-Catherine Wéra; Alison Lobbens; Miroslav Stoyanov; Stéphane Lucas; Carine Michiels
Journal:  Cell Cycle       Date:  2019-06-25       Impact factor: 4.534

Review 4.  Combining immunotherapy and radiotherapy in lung cancer.

Authors:  Neeraj Bhalla; Rachel Brooker; Michael Brada
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

5.  Current prostate cancer treatment: Not what but when?

Authors:  Peter A Massaro; Ilias Cagiannos
Journal:  Can Urol Assoc J       Date:  2016-08       Impact factor: 1.862

Review 6.  Association between radiation-induced cell death and clinically relevant radioresistance.

Authors:  Yoshikazu Kuwahara; Kazuo Tomita; Yusuke Urushihara; Tomoaki Sato; Akihiro Kurimasa; Manabu Fukumoto
Journal:  Histochem Cell Biol       Date:  2018-09-20       Impact factor: 4.304

Review 7.  Radiation-Induced Cardiovascular Toxicity: Mechanisms, Prevention, and Treatment.

Authors:  Johan Spetz; Javid Moslehi; Kristopher Sarosiek
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-03-20

Review 8.  Combining brachytherapy and immunotherapy to achieve in situ tumor vaccination: A review of cooperative mechanisms and clinical opportunities.

Authors:  Ravi B Patel; Claire C Baniel; Raghava N Sriramaneni; Kristin Bradley; Stephanie Markovina; Zachary S Morris
Journal:  Brachytherapy       Date:  2018-08-02       Impact factor: 2.362

9.  Deregulated BCL-2 family proteins impact on repair of DNA double-strand breaks and are targets to overcome radioresistance in lung cancer.

Authors:  Sarah A Wieczorek; Frank Breitenbuecher; Aashish Soni; Katja Paul-Konietzko; Sophie Ziegler; Ali Sak; George Iliakis; Martin Schuler
Journal:  J Cancer Res Clin Oncol       Date:  2017-04-21       Impact factor: 4.553

10.  New paradigms and future challenges in radiation oncology: an update of biological targets and technology.

Authors:  Stanley L Liauw; Philip P Connell; Ralph R Weichselbaum
Journal:  Sci Transl Med       Date:  2013-02-20       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.